Estimate Recalculated Nov 11, 2024 07:52AM EST
Mary Lynne Hedley has an estimated net worth of $7.83 Million. This is based on reported shares across multiple companies, which include VEEVA SYSTEMS INC, Abraxis BioScience, Inc., Receptos, Inc., Centessa Pharmaceuticals plc, bluebird bio, Inc., Millendo Therapeutics, Inc., TESARO, Inc., ELI LILLY & Co, and MGI PHARMA INC.
Mary Lynne Hedley's CIK is 0001340823
2023 was Mary Lynne Hedley's most active year for acquiring shares with 19 total transactions. Mary Lynne Hedley's most active month to acquire stocks was the month of May. 2019 was Mary Lynne Hedley's most active year for disposing of shares, totalling 13 transactions. Mary Lynne Hedley's most active month to dispose stocks was the month of December. 2006 saw Mary Lynne Hedley paying a total of $1,134,750.00 for 95,000 shares, this is the most they've acquired in one year. In 2015 Mary Lynne Hedley cashed out on 27,590 shares for a total of $3,936,614.40, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!